For instance, 99mTc-HYNIC-PSMA has been reported in clinical studies and has shown high uptake in PSMA-positive lesions in patients with prostate cancer [23,24], making it an alternative method for PSMA-specific diagnosis. The gene discussed is FOLH1; the disease is prostate carcinoma.